Biotech RadarJobs updated

COMPANY

Tarsus Pharmaceuticals

HQ: Irvine, CA source · tarsusrx.com ↗ · West Coast

Clinical Phase 3

29 open jobs · last seen Oct 23, 2026 · 15 sources

Keywords: infectious disease Lyme disease Blepharitis Meibomian Gland Dysfunction Ocular Rosacea Demodex Infestation Demodex Blepharitis Demodex Infestation of Eyelid Demodectic Blepharitis Papulopustular Rosacea TP-03 TP-05 (lotilaner) Low Dose TP-05 (lotilaner) High Dose lotilaner

Profile checked Oct 10, 2026

Since the raise (Aug 6, 2026): 29 of 29 open jobs were first seen after it.

29Open jobs$250.0MRaised (2 yrs)12Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Director, HR Business PartnerIrvine, California, United StatesOct 22, 2026Oct 23, 2026
Territory Leader - Houston EastHouston, Texas, United StatesOct 14, 2026Oct 15, 2026
Scientist, PharmacologyIrvine, California, United StatesSep 28, 2026Oct 9, 2026
Director, Formulation DevelopmentIrvine, California, United StatesSep 28, 2026Oct 9, 2026
Manager II, Program Management - Late-Stage DevelopmentIrvine, California, United StatesSep 28, 2026Oct 9, 2026

See all 29 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (29 open jobs at last check). source ↗
  2. Raise Private placement: $125M (total, as published), announced Aug 6, 2026. Source: SEC filing. source ↗
  3. Trial start Phase 2: A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure source ↗
  4. Trial start Phase 2: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) source ↗
  5. Raise Follow-on offering: $125M (total, as published), announced Mar 12, 2025. Source: SEC filing. source ↗
  6. Trial start Phase 4: Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers source ↗
  7. Trial start Phase 2: Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex source ↗
  8. Trial start Phase 2: Study of TP-04 in Participants With Papulopustular Rosacea source ↗
  9. Trial start Phase 1: Study to Evaluate the Food Effect of TP-05 in Healthy Participants source ↗
  10. Trial start Phase 2: A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05 source ↗
  11. Trial start Phase 2: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD source ↗
  12. Trial start Phase 1: A Pharmacokinetic Study of TP-05 in Healthy Subjects source ↗
  13. Trial start Phase 3: Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis source ↗
  14. Trial start Phase 1: A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects source ↗
  15. Trial start Phase 2/Phase 3: Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 29

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Director, HR Business PartnerIrvine, California, United StatesOct 22, 2026Oct 23, 2026Not stated
Territory Leader - Houston EastHouston, Texas, United StatesOct 14, 2026Oct 15, 2026Senior
Scientist, PharmacologyIrvine, California, United StatesSep 28, 2026Oct 9, 2026Mid
Director, Formulation DevelopmentIrvine, California, United StatesSep 28, 2026Oct 9, 2026Senior
Manager II, Program Management - Late-Stage DevelopmentIrvine, California, United StatesSep 28, 2026Oct 9, 2026Senior
Associate Director, Clinical Supply ChainIrvine, California, United StatesSep 28, 2026Oct 9, 2026Senior
Medical Science Liaison (MSL) - Ohio ValleyCincinnati, Ohio, United StatesSep 25, 2026Oct 9, 2026Mid
Territory Leader - JacksonvilleJacksonville, Florida, United StatesSep 24, 2026Oct 9, 2026Senior
Director, Regulatory StrategyIrvine, California, United StatesSep 23, 2026Oct 9, 2026Senior
Director, PharmacologyIrvine, California, United StatesSep 22, 2026Oct 9, 2026Senior
Director, Pharmacokinetics & BioanalysisIrvine, California, United StatesSep 22, 2026Oct 9, 2026Senior
Medical Science Liaison (MSL) - Pennsylvania & New JerseyPhiladelphia, Pennsylvania, United StatesSep 21, 2026Oct 9, 2026Mid
Director, Alliance ManagementIrvine, California, United StatesSep 21, 2026Oct 9, 2026Senior
Territory Leader - PasadenaPasadena, California, United StatesSep 18, 2026Oct 9, 2026Senior
Territory Leader - Ann Arbor & ToledoAnn Arbor, MISep 18, 2026Oct 9, 2026Senior
Territory Leader - WisconsinMadison, Wisconsin, United StatesSep 18, 2026Oct 9, 2026Senior
District Leader - North CentralKansas City, Missouri, United States; Minneapolis, Minnesota, United StatesSep 18, 2026Oct 9, 2026Senior
Medical Science Liaison (MSL) - North CentralChicago, Illinois, United States; Detroit, Michigan, United States; Indianapolis, Indiana, United States; Milwaukee, Wisconsin, United StatesAug 31, 2026Oct 9, 2026Mid
Associate Director, Chemical DevelopmentIrvine, California, United StatesAug 27, 2026Oct 9, 2026Senior
Sr Director, Clinical SciencesIrvine, California, United StatesAug 21, 2026Oct 9, 2026Senior
Sr Director, Regulatory Affairs StrategyUnited States - RemoteJul 30, 2026Oct 9, 2026Senior
Territory Leader - Santa Monica & Hollywood, CALos Angeles, California, United StatesJul 23, 2026Oct 9, 2026Senior
Regional Director, Field Medical Affairs - EastIrvine, California, United StatesJul 17, 2026Oct 9, 2026Senior
Sr Scientist - Analytical DevelopmentIrvine, California, United StatesJul 5, 2026Oct 9, 2026Senior
VP, Clinical DevelopmentIrvine, California, United StatesMay 19, 2026Oct 9, 2026Executive
Manager II, Enterprise Applications (R&D & GxP Systems)Irvine, California, United StatesMay 11, 2026Oct 9, 2026Senior
Director, ToxicologyIrvine, California, United StatesApr 27, 2026Oct 9, 2026Senior
Director, Early Development - Clinical SciencesIrvine, California, United StatesMar 31, 2026Oct 9, 2026Senior
Join Our Talent Community!Irvine, California, United StatesJul 19, 2021Oct 9, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $250.0M. Last 2 years.

Clinical trials (lead sponsor) 12

RecordTitlePhaseStatusStartPrimary completion
NCT07562087A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick ExposurePhase 2Active, not recruitingMar 9, 20262027-10 (estimated)
NCT07443202Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)Phase 2Enrolling by invitationDec 5, 2025Dec 31, 2026 (estimated)
NCT05454956Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDPhase 2CompletedAug 3, 2022May 18, 2023 (actual)
NCT06182358Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens WearersPhase 4CompletedDec 27, 2023Jan 27, 2025 (actual)
NCT05387083A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05Phase 2CompletedDec 12, 2022Jun 26, 2024 (actual)
NCT05138861A Six Week Pharmacokinetic Study of TP-03 in Healthy SubjectsPhase 1CompletedFeb 9, 2021Sep 3, 2021 (actual)
NCT06054217Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexPhase 2Unknown status (ClinicalTrials.gov)Aug 1, 2023Jun 15, 2024 (estimated)
NCT04475432Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisPhase 2/Phase 3CompletedSep 9, 2020May 4, 2021 (actual)
NCT04784091Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisPhase 3CompletedApr 29, 2021May 9, 2022 (actual)
NCT05838170Study of TP-04 in Participants With Papulopustular RosaceaPhase 2CompletedMar 1, 2023Nov 13, 2023 (actual)
NCT05720364Study to Evaluate the Food Effect of TP-05 in Healthy ParticipantsPhase 1CompletedJan 19, 2023May 30, 2023 (actual)
NCT05138796A Pharmacokinetic Study of TP-05 in Healthy SubjectsPhase 1CompletedMay 6, 2021Mar 25, 2022 (actual)

Connect

See your connections at Tarsus Pharmaceuticals on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback